THE SMART TRICK OF ABBV-744 PRECLINICAL STUDIES AND RESULTS THAT NOBODY IS DISCUSSING

In Phase A, individuals will receive various doses and schedules of oral ABBV-744 pill to recognize Protected dosing program. Supplemental contributors will be enrolled at the determined monotherapy dosign regimen. In Phase B, individuals will receive oral ruxolitinib and ABBV-744 is going to be presented as "incorporate-on" therapy. In Phase C, me